Nouvelle déclaration d'incident
No de la demande: 2020-0464
Numéro de référence du titulaire d'homologation: 2019-US-031734
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez un animal domestique
Pays: UNITED STATES
État: UNKNOWN
Inconnu
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2596-139
Nom du produit: Hartz UltraGuard Plus Flea and Tick Collar for Cats and Kittens
Autre (préciser)
CollarOui
Inconnu
Site: Animal / Usage sur un animal domestique
Inconnu
Propriétaire de l'animal
Cat / Chat
Domestic Shorthair
1
Homme
2
Inconnu
Cutanée
Unknown / Inconnu
Unknown / Inconnu
Système
Persisted until death
Oui
Oui
Inconnu
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On an unspecified date a pet owner applied one Hartz UltraGuard Plus Flea and Tick Collar for Cats and Kittens (tetrachlorvinphos, s-methoprene) to their cat. An unspecified amount of time later the cat developed ataxia and seizures. The cat was brought to a veterinary facility where it was received unspecified treatments for several days. The cat died an unspecified amount of time later and was buried. No necropsy was performed. The owner reported purchasing the same product for two other cats in the household but did not specify if the product was applied to those cats. No further information was received.
Mort
Assessment: This product is considered to have a wide margin of safety in cats. If ingested via grooming, only mild signs of oral irritation or gastrointestinal upset including drooling, vomiting, and decreased appetite would be expected. Severe neurological signs and death are not expected following dermal use or small ingestion of the product. Other causes including unknown trauma, infectious disease, underlying metabolic disease, and toxin exposure should be considered given the young age of this cat. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.